1. Home >
  2. M&A >
  3. Stake Purchase >
  4. United Kingdom >
  5. Vitruvian Partners Invests In Oxford Biomedica

Investment Summary

Vitruvian Partners Invests In Oxford Biomedica

On February 5, 2021, private equity firm Vitruvian Partners invested in life science company Oxford Biomedica

Investment Highlights
  • This is Vitruvian Partners’ 2nd transaction in the Life Science sector.
  • This is Vitruvian Partners’ 24th transaction in the United Kingdom.

Investment Summary
Date 2021-02-05
Target Oxford Biomedica
Sector Life Science
Investor(s) Vitruvian Partners
Deal Type Stake Purchase

Target

Oxford Biomedica

Oxford, United Kingdom
Oxford Biomedica is a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno associated virus, adenoviral vectors, and other viral vector types. Oxford Biomedica was founded in 1995 and is based in Oxford, United Kingdom.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Vitruvian Partners

London, United Kingdom
Category Private Equity Firm
Founded 2006
PE ASSETS 20.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Vitruvian Partners is an independent private equity firm that specializes in middle-market buyouts, growth buyouts and growth capital investments in the UK and elsewhere in Northern Europe. Vitruvian looks for companies that are 'operating in dynamic situations, where there is an opportunity to build strategic value'. The Group's target investment size is €40 to €600 million in transactions valued between €75m to €4bn. Sectors of interest include business services, consumer services, financial services, life science, healthcare services, media, technology, communications, and internet software. Vitruvian Partners was formed in 2006 and is based in London.

DEAL STATS #
Overall 46 of 69
Sector: Life Science M&A 2 of 3
Type: Stake Purchase M&A Deals 5 of 11
Country: United Kingdom M&A 24 of 28
Year: 2021 M&A 3 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-01 Expereo International

Amsterdam, Netherlands

Expereo International is a provider of managed Internet network services, SD-WAN, Security and Cloud Connectivity optimisation solutions for global enterprises. Expereo International was founded in 2004 and is based in Amsterdam, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-18 CarGurus

Cambridge, Massachusetts, United States

CarGurus is an online automotive marketplace connecting buyers and sellers of new and used cars. Using proprietary technology, search algorithms, and innovative data analytics, CarGurus believes it is building the world's most trusted and transparent automotive marketplace and creating a differentiated automotive search experience for consumers. CarGurus was founded in 2005 and is based in Cambridge, Massachusetts.

Buy -
Mergr

Solution for

Product

Company

Legal